Co.Design: How Designers are Helping HIV Researchers Find a Vaccine

Rethinking how scientists share data -- especially the inconclusive results -- may be the key.

By Mark Wilson

The Collaboration for AIDS Vaccine Discovery (CAVD) consists of a group of labs across the world, all pooling their data with one goal in mind: to create an AIDS vaccine as fast as possible. But the theory of sharing vast amounts of data is easier than the practice.

UW Daily: Turning the tide on HIV

By Chelsea Gish

The ASPIRE trial and The Ring Study, two large scale clinical trials, have found that microbicides can safely reduce the risk of new HIV infections in women.

A microbicide is any compound capable of destroying microbes and infectious agents. Recently, this method of prevention has become particularly relevant in reducing the transmission of HIV when applied to the vaginal or rectal region as a topical gel.

...

NewsBeat: Microbicide Reduces Women's HIV Risk in Large-Scale Trial

By Lisa Rossi

Two large clinical trials have found that a microbicide prevention method can safely help reduce new HIV infections in women.

Results of the ASPIRE trial, which enrolled more than 2,600 women in Africa, were announced today at the Conference on Retroviruses and Opportunistic Infections in Boston. The results also will be published online in the New England Journal of Medicine.

HIV Prevention and Counseling at Holy Water Sites in Ethiopia

By Kate Pfizenmaier, SCOPE Program Manager

Strengthening Care Opportunities through Partnership in Ethiopia (SCOPE), a program in the Department of Global Health, empowers religious leaders to be health advocates in their communities.  One way SCOPE does this is by encouraging Ethiopian priests to educate people at holy water sites on the importance of HIV testing, counseling, and treatment.

Pages